Reducing the harm from alcohol
Tuesday, 12 February 2013 10:34
This one-day CPD-accredited conference on 9 December 2013 will examine the UK, European and global trends in consumption and harm from alcohol and the evidence for the effectiveness of policy at local, national and international levels. The day will draw on the differing experiences of the devolved nations and will examine the impact of developing local hospital policies for the management of alcohol problems and their outreach into the community. By attending the conference delegates will be better placed to understand what works in implementing effective change, developing local services, and critically evaluating the evidence and will be more effective advocates with policy makers, the public and the media. The conference is co-badged by the BSG and BASL. Further details are available on the RCP website.
IBD Registry Update
Monday, 11 February 2013 12:05
The first of three pilot sites for the UK IBD Registry started trialling the system on Tuesday 15th January. Launching later this year, the Registry will provide the first ever UK-wide repository of anonymised IBD patient data for prospective audit and research. By bringing this data together for the first time, the Registry Board aims to:
- Provide local, regional & national data in order to better define the pattern of ulcerative colitis and Crohn's disease
- Improve understanding of long term outcomes
- Drive continuous improvement in patient care and access to care across the UK
- Inform commissioning and service design
- Support IBD research
Data can be entered either from existing databases, via a web portal, or by means of a new IBD Patient Management System (PMS), which has been developed by Chameleon Information Systems Ltd (suppliers of InfoFlex) under the guidance of Clinical Lead, Fraser Cummings. Fraser and his team have designed the PMS so that data can be easily entered during the consultation. The PMS will also provide real-time benefits such as a clinical summary of each patient at a glance, to save time leafing through paper notes, and work lists to support, for example, azathioprine monitoring, biologics follow-up or MDT meetings. Subject to local IT arrangements, the PMS can also be integrated with local PAS to further minimise data entry.
The pilot stage is due to run till March, and the launch of the Registry is scheduled for the BSG conference in June.
- Further information [ 77 kb ]
BSG Response to Consultation on the Government's Alcohol Strategy
Thursday, 07 February 2013 17:52
Tom Smith, BSG Chief Executive
The British Society of Gastroenterology is continuing to lobby in the interests of our members, and patients, across gastroenterology and hepatology. As I am sure you are aware, the Government is currently consulting on their Alcohol Strategy which includes provision for a minimum unit price for alcohol of 45p. The BSG is working closely with partners in the Alcohol Health Alliance (AHA) to ensure that this minimum unit price is brought into action and that it is set at the more effective price of 50p. This is a significant moment in the push for measures to deal with the increasing problems that alcohol poses to the nation's health and we must seize on the opportunity to demonstrate the widespread support of health professionals for these measures. The BSG & AHA have submitted their responses. (The BSG response may be viewed via the link below).
- View BSG response [ 650 kb ]
NICE Alcohol Evidence Update 2013
Thursday, 07 February 2013 16:34
'Alcohol use disorders: harmful drinking and alcohol dependence Evidence Update January 2013'
NICE has released a summary of selected new evidence relevant to its clinical guideline 'Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence' (2011)
Evidence Updates provide a summary of selected new evidence published since the literature search was last conducted for the accredited guidance they relate to. They reduce the need for individuals, managers and commissioners to search for new evidence. Evidence Updates highlight key points from the new evidence and provide a commentary describing its strengths and weaknesses. They also indicate whether the new evidence may have a potential impact on current guidance. For contextual information, this Evidence Update should be read in conjunction with the relevant clinical guideline, available from the NHS Evidence topic page for alcohol.
- Download evidence update [ 394 kb ]
Page 5 of 16